Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market Restraint
Increasing product recalls are expected to hinder the growth of the percutaneous transluminal coronary angioplasty (PTCA) balloon catheter market over the forecast period. For instance, in February 2020, Abbott, a medical device and healthcare company, had voluntarily recalled specific lots of two types of its coronary angioplasty catheters – NC Trek RX Coronary Dilatation Catheter and NC Traveler Coronary Dilatation Catheter, as the balloons from the impacted lots may not deflect as intended, and the U.S Food and Drug Administration has classified this as Class I recall.
Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients